Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Change in Account Payables (2023 - 2026)

Scynexis' (SCYX) quarterly Change in Account Payables came in at -$472000.0 in Q2 2026, down 124.69% on a YoY basis from $1.9 million in Q2 2025, and down 152.1% quarter-over-quarter from $906000.0 in Q1 2026.

Analysis

Scynexis (SCYX) Change in Account Payables (2023 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Change in Account Payables for 4 consecutive years, with -$472000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Account Payables fell 124.69% year-over-year to -$472000.0; the trailing twelve-month figure through Jun 2026 stood at -$3.5 million (down 527.37% YoY), and the FY2025 full-year result was -$2.2 million, up 15.7% from the prior year.
  • Change in Account Payables eased to -$472000.0 in Q2 2026 per SCYX's latest filing, from $906000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $3.6 million in Q4 2023 and bottomed at -$3.6 million in Q2 2024.
  • Historically, Change in Account Payables has averaged -$234142.9 across 4 years, with a median of -$303000.0 in 2024.
  • The widest YoY moves for Change in Account Payables: up 15175.0% in 2024, down 650.0% in 2024.
  • Over 4 years, Change in Account Payables stood at $3.6 million in 2023, then sank by 113.37% to -$484000.0 in 2024, then slumped by 156.61% to -$1.2 million in 2025, then jumped by 62.0% to -$472000.0 in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$472000.0, $906000.0, and -$1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -70.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 18.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -66.70 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -8.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 7.11 Mn
10 Scynexis 58.41 Mn -56.29 Mn - -472,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -472,000.00
Mar 31, 2026 906,000.00
Dec 31, 2025 -1.24 Mn
Sep 30, 2025 -2.71 Mn
Jun 30, 2025 1.91 Mn
Mar 31, 2025 -199,000.00
Dec 31, 2024 -484,000.00
Sep 30, 2024 -407,000.00
Jun 30, 2024 -3.57 Mn
Mar 31, 2024 1.81 Mn
Dec 31, 2023 3.62 Mn
Sep 30, 2023 74,000.00
Jun 30, 2023 -2.51 Mn
Mar 31, 2023 -12,000.00